Rand Paul Demands New Scrutiny of Overseas Biolabs After Gabbard Declassifies US-Backed Research Documents

Director of National Intelligence Tulsi Gabbard declassified a sweeping trove of documents on June 12, 2026, revealing that the U.S. government has funded biological research at more than 120 laboratories across 30 countries, according to ODNI. Senator Rand Paul immediately called for a presidential commission to audit every U.S.-supported lab abroad, saying the documents prove what critics had long dismissed as fringe theory.
Paul, who chairs the Senate Homeland Security Committee, accused the intelligence community and federal agencies of spending years blocking congressional oversight. "They were pulling teeth to keep this from Congress," he said. The release came just days before Gabbard's scheduled departure as DNI on June 19, 2026, according to Fox San Antonio.
The declassified files show the Pentagon spent at least $11 million on construction and equipment for biological labs in Ukraine alone, according to KTUL. More than 40 U.S.-supported sites operated inside Ukraine, including a $3.49 million Central Reference Laboratory at the country's Anti-Plague Research Institute. For years, U.S. and Ukrainian officials described the facilities as purely civilian public health labs.
Gabbard said the American public had been "knowingly lied to" about the existence and purpose of these sites. The documents show that research into "especially dangerous pathogens" was conducted at many of these facilities, funded through Pentagon military budgets rather than civilian health agencies, according to News Channel 9.
Paul is pushing two major responses. First, he wants a presidential commission to review all U.S.-funded biological research globally. Second, his Risky Research Review Act passed the Senate Homeland Security Committee in a bipartisan 11-2 vote in July 2025, according to CBS Austin. The bill would create an independent Life Sciences Research Security Board to approve research grants, replacing the NIH's current role.
Paul argued that the NIH has proven it cannot police itself, pointing to the EcoHealth Alliance controversy and years of disputed gain-of-function research funding. He said bureaucrats used classification rules as a shield to prevent Congress from learning the full scope of the programs, according to WGME.
The debate got a fresh jolt on June 2, 2026, when NIH virologists Vincent Munster and Claude Kwe were charged with conspiracy to smuggle monkeypox virus samples into the United States. Prosecutors say the two scientists brought 113 microcentrifuge tubes — containing monkeypox and chickenpox samples — back from the Congo in January 2024 without declaring them, according to KOMO News.
Paul cited the charges as proof of a "culture of biosafety recklessness" inside federal agencies. The arrests strengthened his argument that existing oversight has failed and that an independent review body is needed before any further research moves forward, according to My News 4.
Not everyone sees the declassification as a victory for transparency. Some analysts and media outlets argue the documents are being misread. They say storing dangerous pathogens for disease monitoring and vaccine work is standard global practice, and that labeling these sites as covert bioweapons labs mirrors a long-running Russian influence campaign, according to News 3 Las Vegas.
The American Society for Microbiology has warned that Paul's proposed oversight board could slow legitimate medical research and vaccine development by putting non-experts in charge of complex grant decisions. Diplomatic concerns are also real: Russia has used the disclosure to renew accusations of biological warfare preparations by the U.S., which could complicate any future peace talks over Ukraine, according to WWMT.
Publishers
20
Articles
19
Reach
20